Professional Documents
Culture Documents
2.3 General Anesthesia
2.3 General Anesthesia
3
GENERAL ANESTHESIA
August 1, 2019 | Kathrina V. Suarez-Ramos, MD (Part 1) & Eileen Jane Robledo-Palamos, MD (Part 2)
Transcriber/s: Group 1A
ADVANTAGES OF GENERAL ANESTHESIA
Red – recording and transcriber’s notes Patient’s cooperation is not absolutely essential for the success
GENERAL ANESTHESIA of the GA (ideal for uncooperative children)
It is a drug-induced loss of consciousness during which an Proper muscle relaxation for a prolonged period
individual is not arousable even by painful stimulation. Proper control of the airway, breathing and circulation
During GA, the ability to maintain ventilator function is often Amnesia is present, less intra-op awareness and recall
impaired because breathing becomes very shallow. Can be adapted easily to procedures of unpredictable duration
The individual often requires assistance in maintaining a patent Rapid onset of action, titration is possible, and reversible
airway and positive airway ventilation may be required because GA may be the only technique that will prove successful for
of depressed spontaneous ventilation or drug induced certain patients
depression of neuromuscular function.
Features: DISADVANTAGES OF GENERAL ANESTHESIA
o Lack of consciousness Requires increased complexity of care and associated costs
o Amnesia – patients forget any unpleasant events that Requires some degree of preoperative patient preparation
happened during the procedure or surgery Can induce physiologic fluctuations that require active
o Analgesia – no pain intervention because we are inducing an abnormal state
o Attenuation of autonomic response (abnormal in a sense of the patient forgetting everything)
o Neuromuscular blockade Complications like nausea, vomiting, headache, sore throat,
o All should be present when patient is under GA for it to be shivering, and delayed return to normal mental functioning
balanced Associated with malignant hyperthermia, particularly with
Stages: inhalational agents and muscle relaxants. It can be fatal if not
I. Analgesia/sedation managed properly.
II. Delirium or Excitation
III. Surgical anesthesia COMPLICATIONS
IV. Medullary depression GA is overall VERY SAFE it is not the anesthesia itself that gives
the complications but the procedure the patient undergoes
STAGE I: ANALGESIA/SEDATION including one’s comorbidities.
Period between the initial drug administration and loss of Most people, even those with significant health conditions are
consciousness able to undergo GA itself without serious problems.
A very short period from the time of administration until the Risk of complication is more closely related to the:
time that the patient falls asleep o Type of procedure (elective vs. emergency)
o Patient is still awake/conscious o General physical health rather than TYPE of anesthesia
o Spontaneous respiration o Elective procedures have better outcomes than ER
o Reflexes are present procedures because elective procedures have allowed
o Possible small surgery procedures (dressing change in burns) patients to prepare beforehand.
1 of 8
Intravenous
PHARMACODYNAMICS OF INHALATIONAL ANESTHETICS
INHALATIONAL ANESTHESIA MINIMUM ALVEOLAR CONCENTRATION (MAC)
The patient must receive an ADEQUATE: It is the alveolar concentration of an inhaled anesthetic that
Concentration of oxygen to prevent hypoxia prevents movement in 50% of patients in response to a
Concentration of anesthetic to prevent awareness and recall standardized stimulus (e.g. surgical incision). The other 50% can
Flow of fresh gas to prevent hypercarbia still react to the painful stimulus, that’s why when we give GA,
PHARMACOKINETICS OF INHALATIONAL ANESTHETICS even if 1 MAC is adequate to intubate the patient, we increase
that to 1.3 MAC to maintain pain free and to not wake up.
MAC 1.3 is the ED 95 or effective dose at which 95% of the
patients will not move/react to the painful stimulus. The muscle
relaxants, opioids, or BZDs will cover for the remaining 5%.
It is a useful measure because it mirrors brain partial pressure,
allows comparisons of potency between agents and provides a
standard for experimental evaluations
It is a median value with limited usefulness in managing
individual patients, particularly during times of rapidly changing
alveolar concentrations (e.g. induction)
It can be altered by several physiological and pharmacological
variables (e.g. 6% decrease in MAC per decade of age, regardless
of volatile anesthetic why we decrease the MAC in the elderly)
Involves:
Factors affecting INSPIRATORY CONCENTRATION (FI)
o Fresh gas flow rate (from the machine)
o Volume of the breathing system NITROUS OXIDE (MAC 105)
o Any absorption by the machine or breathing circuit ● Commonly known as laughing gas; also used by dentists and vets
o The higher the FGF rate, the smaller the breathing system ● Only inorganic anesthetic gas used clinically
volume, and the lower the circuit absorption, the closer ● Sweet smelling and non-flammable, of low potency
the inspired gas concentration will be to the fresh gas ● Limited blood and tissue solubility
concentration ● Often administered as an adjuvant in combination with other
Factors affecting the ALVEOLAR CONCENTRATION (FA) (Most volatile anesthetics or opioids
important factor)
o Uptake HALOTHANE (MAC 0.75)
o Ventilation ● Halogenated alkane
o Concentration ● Non-flammable, non-explosive
o The alveolar concentration ultimately is the principal ● Colorless, pleasant smelling so it was often used for pediatric GA
factor in determining the onset of action of the drug ● Immune-mediated HEPATITIS
Factors affecting the ARTERIAL CONCENTRATION (Fa) ○ rare; 1 in 35,000
o Ventilation/Perfusion Mismatch ○ More common in obese, mid-aged women,
Increases alveolar partial pressure and decreases patients exposed to Hep B, and with a family hx
arterial partial pressure of hepatitis
Factors affecting the ELIMINATION ● Most potent BRONCHODILATOR
o The most important route for elimination of inhalational ● Sensitizes myocardium to the effect of catecholamines
anesthesia is the alveolus (producing Preventricular contractions, tachydysrhythmias)
o Recovery depends on lowering anesthetic concentrations ● Potent uterine relaxation
in the brain through: biotransformation (minimal),
transcutaneous loss (very minimal) and exhalation (main) ISOFLURANE (MAC 1.2)
● Halogenated methyl ethyl ether
ELIMINATION ● Coronary vasodilatation is characteristic
Factors that speed induction, speeds recovery: ● CORONARY STEAL phenomenon
● Elimination of re-breathing ● Less myocardial depression compared to other inhalational
● High fresh gas flows anesthetics
● Low anesthesia circuit volume ● High degree of solubility
● Low absorption by the circuit ● Negligible amount of organic fluoride
● Decreased solubility
● High cerebral blood flow (CBF) ENFLURANE (MAC 1.7)
● Increased ventilation ● Halogenated ether
2 of 8
● Non-flammable thalamus (which relays sensory impulses from the RAS to the
● Airway irritant, clear, strong smell cerebral cortex) from the limbic cortex (which is involved with
● Seizure-like activity on EEG at high concentration the awareness of sensation)
● Inorganic fluoride may cause toxicity ● Also used by veterinarians
● Removed from the market due to induced tonic-clonic seizures ● Used as one of the date-rape drugs
in prolonged surgeries ● Nystagmus; some involuntary muscle movement
● Hallucinations during emergence
SEVOFLURANE (MAC 1.8) ● Sympathetic stimulation, increase HR and BP
● One of the most recent & most popular inhalational anesthetics, ○ avoided in elderly patients and patients with
good for pediatrics tachyarrhythmias.
● Completely fluorinated methyl isopropyl ether ○ May be advantageous in hypotensive,
● Rapid induction and emergence hypovolemic, and burn patients
● Relatively stable CV effect, non-arrythmogenic ● Potent bronchodilator.
● Minimal odor and pungency so that induction can be done ○ Good to use for patients with asthma.
mainly through inhalation
● Potent bronchodilator PROPOFOL
● Highly dependent on liver metabolism ● MOA: involve facilitation of inhibitory neurotransmission
mediated by GABA receptor binding; inhibits synaptic
DESFLURANE (MAC 6) transmission at the GABA receptor
● Completely fluorinated methyl ethyl ether (resists ● Total intravenous anesthetic (TIVA)
biodegradation) ● Alkylated phenol
● Fast induction and emergence (lowest blood:gas solubility) ● Short duration, rapid recovery
● Can be used in “low flow“ technique ○ Commonly used in day
● Requires a heated and pressurized vaporizer surgery/out-patient
● Pungent; not used for purely inhalational induction procedures
● Boils at room temperature needs a special temperature- ● Low incidence of nausea and vomiting
controlled vaporizer; not used in DLSUMC ● Bronchodilator effect
● Not given to patients in the ER
INTRAVENOUS ANESTHESIA
BARBITURATES TOTAL INTRAVENOUS ANESTHESIA (TIVA)
● MOA: depresses the reticular activatingsystem in the brainstem, Only applicable to propofol. SPECIFIC TO PROPOFOL
which controls multiple vital functions including consciousness; o Only propofol is used for induction,
inhibits excitatory synaptic transmission to GABA receptors maintenance, until the end of the procedure
● Target: Dorsal horn (pain pathway) o If other drugs are used sometime during the
● Thiopental: anesthesia it is NOT TIVA.
○ Rapid onset but causes apnea when given fast ADVANTAGES:
○ Anticonvulsant The potential toxic effects of inhalational anesthetic are avoided
○ Causes hypotension and myocardial depression A better quality of recovery is claimed
○ Ideal for short diagnostic procedures May be beneficial to certain types of surgery (e.g. Neurosurgery)
○ Poor analgesic property decreases ICP, improves blood flow
○ “Truth serum” Pollution is reduced
○ Part of the lethal injection, inducing sleep/sedation Better choice for ENT- mastoidectomy and tympanoplasties
● Common Barbiturates:
AGENT USE ROUTE DISADVANTAGES:
Thiopental Induction IV Secure, reliable IV access is required
Methohexital Induction IV The risk of awareness if IV infusion fails
Sedation IV Cost of electronic infusion pumps
Induction Rectal (children) May cause profound hypotension for long procedures
Secobarbital, Premedication Oral
Pentobarbital IM ETOMIDATE
Rectal suppository MOA: depresses the RAS & mimics the inhibitory effect of GABA
Unlike barbiturates, may have disinhibitory effects on the parts
of the nervous system that control extrapyramidal motor activity
Recording: The GAs act on the entire CNS. But there are
30-60% incidence of myoclonus with etomidate at induction of
particular areas in the CNS that they affect. It is the RAS,
anesthesia
Cerebral cortex, Limbic System, and the entire spinal cord,
Not for maintenance of anesthesia
particularly the dorsal horn where the pain receptors lie. The
AGENT USE ROUTE
RAS, Cerebral cortex, Limbic system involve consciousness, and
Induction IV, IM
memory; the dorsal horn contains the pain pathways. Ketamine
Sedation IV
Etomidate Induction IV
KETAMINE Induction IV
● MOA: has been demonstrated to be an N-methyl-D- Propofol Maintenance Infusion IV
aspartate(NMDA) receptor (a subtype of the glutamate Sedation Infusion IV
receptor) antagonist
● DISSOCIATIVE ANESTHESIA: functionally dissociates the EMERGENCE FROM ANESTHESIA
3 of 8
“Waking the patient up” ANATOMY OF THE AIRWAY: NERVE SUPPLY/INNERVATION
Priorities:
o Recovery of consciousness
o Maintenance of a patent airway
BENZODIAZEPINES
Given to combative patients in the ER
MOA: bind the same set of receptors in the CNS as barbiturates
but bind to a different site on the receptors
AGENT USE ROUTE
Premedication Oral
Diazepam
Sedation IV
Premedication IM
Midazolam Sedation IV
Induction IV
Lorazepam Premedication Oral
AIRWAY MANAGEMENT
To maintain an open airway and enable mechanical ventilation, an Figure 4. Anatomy of the Trachea
endotracheal tube (ETT) or a laryngeal mask airway (LMA) is used.
NERVE SUPPLY/INNERVATION
• CN VII (Facial)
• CN IX (Glossopharyngeal)
• CN X (Vagus)
4 of 8
BMV capability
Laryngoscopes ( direct and video )
Endotracheal tubes of different sizes
Other airway devices: eg. oral, nasal airways
Suction
Oxymetry and CO2 detection (pulse oximeter and capnograph)
Stethoscope
Tape
Blood pressure and ECG monitors
Intravenous access
5 of 8
COMPLICATIONS OF INTUBATION
Malpositioning
i.e: breath sounds only on the R and none on the L, do not
re-intubate.
o Absence of breath sounds on one lung may
(usually on the left) may be an indication that
the tube is too far in and is only providing
ventilation for one lung. (Remember in anatomy
that the R bronchus is more vertically positioned
making it easier to access and prone to
aspiration)
Figure 7. The Sniffing Position
Solution: pull the tube a little bit back to a position where
it would ventilate both lungs. The tube must end before
PRE-OXYGENATION (NOT DISCUSSED)
the bifurcation of the main bronchus (around the carina).
Usually done with a face mask oxygen
Precedes all airway management interventions
The FRC, the patient’s O2 reserve is purged of nitrogen
The pre-oxygenated patient may have a 5 to 8 minute reserve
(improves safety)
Airway trauma
Physiologic reflexes: airway is innervated by the vagus nerve
causing bradycardia - give atropine
Tune malfunction
EFFECTS OF LARYNGEAL NERVE INJURY
6 of 8
3. VIDEO LARYNGOSCOPY o Instead, if difficult to intubate, intubate while
awake and without relaxants
Interrupt transmission at the neuromuscular junction
Provide skeletal muscle relaxation including the diaphragm
Muscle relaxants only affect skeletal muscles
o Will not cause uterine relaxation because the
uterus is a smooth muscle
o Includes the muscles or respiration which
includes the diaphragm.
Muscle relaxants are used to:
o Improve conditions for tracheal intubation
Without paralysis of the muscles of respiration,
FLEXIBLE FIBEROPTIC INTUBATION (NOT DISCUSSED) BP may go up due to difficulty in intubation.
Is routinely performed in awake or sedated patients with Outside the OR where equipment is limited,
problematic airways. small doses of sedatives are used instead of
FOI is ideal for: muscle relaxants to avoid the risk of cessation of
o A small mouth opening
spontaneous breathing due to muscle paralysis.
o Minimizing cervical spine movement in trauma or o Provide immobility during surgery thus optimizing surgical
rheumatoid arthritis condition
o Upper airway obstruction, such as angioedema or tumor o Facilitate mechanical ventilation
mass o To provide abdominal relaxation if the procedure is very
o Facial deformities or facial trauma long. Especially in the absence of epidural anesthesia.
FOI can be performed awake or asleep via oral or nasal routes.
Awake FOI: predicted inability to ventilate by mask, upper
airway obstruction
Asleep FOI: failed intubation, desire for minimal C spine
movement in patients who refuse awake intubation
Oral FOI: Facial, skull injuries
Nasal FOI: poor mouth opening
7 of 8
to its receptor= no contraction
There is a wide selection compared to depolarizing relaxants. E.g
Rocuronium (intermediate acting)
Based on chemical structures, can be classified as
BENZYLISOQUINOLINIUM, STEROIDAL or other compounds
(CHLOROFUMARATE)
Sugammadex – only reversal agent available. Reverses
Rocuronium
Cholinesterase inhibitors (Neostigmine, Pyridostigamine,
Edrophonium) – reverses the effect of non-depolarizing NMB by
inhibiting acetylcholinesterase thereby flooding the NMJ with
acetylcholine.
Medications that POTENTIATE non-depolarizing muscle
relaxants:
8 of 8